IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — CLYM

Balance Sheet

(in millions USD)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021
Cash & Equivalents8.3625.8022.6829.02146.18223.14105.0357.3525.2934.4435.9432.6031.9362.8299.48
Short-term Investments101.2161.1062.0269.0447.180.000.0050.0877.3474.9486.6890.3592.0183.20--
Total Current Assets113.4090.9687.38100.28197.61226.00109.22112.43114.24120.17133.17133.08133.28158.63104.80
Property, Plant & Equipment0.250.320.31------------------------
Total Non-current Assets*38.9791.34105.00100.4624.590.020.110.302.031.917.6917.0329.1423.622.82
Total Assets152.37182.30192.39200.74222.20226.02109.33112.74116.27122.09140.86150.10162.42182.25107.63
Accounts Payable0.860.480.950.780.290.510.090.740.880.861.491.060.852.581.96
Total Current Liabilities4.074.956.217.043.423.742.952.903.624.926.287.616.905.595.71
Total Non-current Liabilities*0.220.350.420.320.000.000.000.090.160.310.220.260.380.000.00
Total Liabilities4.295.306.627.363.423.742.952.993.775.236.507.877.285.595.71
Retained Earnings(303.45)(272.21)(259.32)(250.66)(221.46)(212.56)(157.68)(152.34)(148.37)(143.15)(113.10)(103.42)(88.82)(65.07)(55.46)
Total Stockholder Equity148.09177.00185.76193.39218.78222.28106.38109.74112.50116.86134.36142.24155.14176.66(50.84)

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Research & Development9.3713.749.076.5817.335.956.091.051.093.132.883.695.725.114.268.748.116.595.705.48
Selling, General & Admin5.845.565.824.105.694.955.493.671.912.002.133.0317.724.634.494.934.873.823.392.91
Total Operating Expenses15.2119.3014.8910.6823.0210.9111.7356.373.015.125.006.7123.449.558.7513.7013.1310.709.388.71
Operating Income(15.21)(19.30)(14.89)(10.68)(23.02)(10.91)(11.73)(56.37)(3.00)(5.12)(5.00)(6.71)(23.44)(9.55)(8.75)(13.70)(13.13)(10.70)(9.38)(8.71)
Pretax Income*--------(20.78)(8.42)(8.89)(54.89)--(3.64)(3.97)(5.22)(22.29)--------------
Tax Provision--------0.000.000.000.00--0.000.000.000.00--------------
Net Income(13.72)(17.52)(12.89)(8.67)(20.78)(8.42)(8.89)(54.89)(1.70)(3.64)(3.97)(5.22)(22.29)(7.76)(9.68)(14.60)(13.20)(10.54)(9.61)(8.72)
Basic EPS(0.20)(0.25)(0.19)(0.13)(0.31)0.47(0.13)(1.81)(0.06)(0.12)(0.15)(0.19)(0.84)(0.29)(0.37)(0.56)--------
Diluted EPS(0.20)(0.25)(0.19)(0.13)(0.31)0.47(0.13)(1.81)(0.06)(0.12)(0.15)(0.19)(0.84)(0.29)(0.37)(0.56)--------

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Operating Cash Flow(14.38)(15.63)(12.14)(11.15)(15.43)(5.52)(7.55)(0.67)(1.82)(0.95)3.49(7.96)(15.18)(8.45)(4.17)(13.97)(10.78)(7.88)(12.97)(15.22)
Capital Expenditures--0.000.000.08--0.000.004.64------------------------
Free Cash Flow*--(15.63)(12.14)(11.22)--(5.52)(7.55)(5.31)------------------------
Investing Cash Flow(12.95)25.5415.264.79(42.75)(53.41)(71.79)(9.64)13.7536.7528.04(1.60)5.8014.288.5115.69(4.03)(8.05)(106.92)--
Financing Cash Flow0.01(0.02)0.000.000.000.042.27128.400.020.290.530.020.000.000.000.000.000.0483.1494.05

* Derived from reported values